Zoutman DE, Ford B, Bryce E, Gourdeau M, Hebert G, Henderson E, et al. The state of infection surveillance and control in Canadian acute care hospitals. Am J Infect Control. 2003;31(5):266–73.
Article
PubMed
Google Scholar
Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control. 2005;33(9):501–9.
Article
PubMed
Google Scholar
Al-Tawfiq JA, Tambyah PA. Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014;7(4):339–44.
Article
PubMed
Google Scholar
Storr J, Twyman A, Zingg W, Damani N, Kilpatrick C, Reilly J, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control. 2017;6(5):6.
Article
PubMed
PubMed Central
Google Scholar
Scheckler WE, Brimhall D, Buck AS, Farr B, Friedman C, Garibaldi R, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1998;19(2):114–24.
Article
CAS
PubMed
Google Scholar
Bryant KA, Harris AD, Gould CV, Humphreys E, Lundstrom T, Murphy D, et al. Necessary infrastructure of infection prevention and healthcare epidemiology programs: a review. Infect Control Hosp Epidemiol. 2016;37(4):371–80.
Article
PubMed
Google Scholar
Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis. 2010;50(7):1017–21.
Article
PubMed
Google Scholar
Drummond MF, Davies LM. Evaluation of the costs and benefits of reducing hospital infection. J Hosp Infect. 1991;18(Supplement A):85–93.
Article
PubMed
Google Scholar
Whittington MD, Atherly AJ, Curtis DJ, Lindrooth RC, Bradley CJ, Campbell JD. Recommendations for methicillin-resistant Staphylococcus aureus prevention in adult ICUs: a cost-effectiveness analysis. Crit Care Med. 2017;45(8):1304–10.
Article
PubMed
Google Scholar
Li CK, Tong BCY, You JHS. Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy. Int J Infect Dis. 2016;43:7–12.
Article
CAS
PubMed
Google Scholar
Hayman DTS, Marshall JC, French NP, Carpenter TE, Roberts MG, Kiedrzynski T. Cost benefit analyses of supplementary measles immunisation in the highly immunized population of New Zealand. Vaccine. 2017;35(37):4913–22.
Article
CAS
PubMed
Google Scholar
Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies. Canada; 2017. https://www.cadth.ca/guidelines-economic-evaluation-health-technologies-canada-4th-edition. Accessed 15 Jan 2018
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated health economic evaluation reporting standards (CHEERS)--explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–50.
Article
PubMed
Google Scholar
Bravo Vergel Y, Sculpher M. Quality-adjusted life years. Pract Neurol. 2008;8(3):175–82.
Article
PubMed
Google Scholar
Drummond MF, Sculpher M, Claxton K, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes. Fourth ed. New York: Oxford University Press; 2015.
Google Scholar
Graves N, Halton LD. Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol. 2007;28(2):178–84.
Article
PubMed
Google Scholar
Raschka S, Dempster L, Bryce E. Health economic evaluation of an infection prevention and control program: are quality and patient safety programs worth the investment? Am J Infect Control. 2013;41(9):773–7.
Article
PubMed
Google Scholar
Leonhardt KK, Yakusheva O, Phelan D, Reeths A, Hosterman T, Bonin D, et al. Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals. Infect Control Hosp Epidemiol. 2011;32(8):797–803.
Article
PubMed
Google Scholar
Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control. 2002;30(3):145–52.
Article
PubMed
Google Scholar
Arefian H, Vogel M, Kwetkat A, Hartmann M. Economic evaluation of interventions for prevention of hospital acquired infections: a systematic review. PLoS One. 2016;11(1):e0146381.
Article
PubMed
PubMed Central
Google Scholar
Roberts RR, Ek M, Weinstein RA. A guide to interpreting economic studies in infectious diseases. Clin Microbiol Infect. 2010;16(12):1713–20.
Article
CAS
PubMed
Google Scholar
Dick A, Perencevich EN, Pogorzelska-Maziarz M, Zwanziger J, Larson EL, Stone PW. A decade of investment in infection prevention: a cost effectiveness analysis. Am J Infect Control. 2015;43(1):4–9.
Article
PubMed
PubMed Central
Google Scholar
Stone PW, Schackman BR, Neukermans CP, Olchanski N, Greenberg D, Rosen A, et al. A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis. 2005;5(6):383–91.
Article
PubMed
Google Scholar
Pettitt DA, Raza S, Naughton B, Roscoe A, Ramakrishnan A, Ali A, et al. The limitations of QALY: a literature review. J Stem Cell Res Ther. 2016;6:334–6.
Google Scholar
Knapp M, Mangalore R. The trouble with QALYs.... Epidemiol Psychiatr Soc. 2007;16(4):289–93.
Article
Google Scholar
Ogwulu CB, Jackson LJ, Kinghorn P, Roberts TE. A systematic review of the techniques used to value temporary health states. Value Health. 2017;20(8):1180–97.
Article
PubMed
Google Scholar
Cunningham SJ. Economic evaluation of healthcare-is it important to us? Br Dent J. 2000;188(5):250–4.
CAS
PubMed
Google Scholar
Gu N, Wolf C, Leopold S, Manner PA, Doctor JN. A comparison of physician and patient time trade-offs for postoperative hip outcomes. Value Health. 2009;12(4):618–20.
Article
PubMed
Google Scholar